Hepatocyte activation and liver injury following cerebral ischemia promote HMGB1-mediated hepcidin upregulation in hepatocytes and regulation of systemic iron levels
0
조회
0
다운로드
0
인용
0
참고문헌
초록
We previously reported that high mobility group box 1 (HMGB1), a danger-associated molecular pattern (DAMP), increases intracellular iron levels in the postischemic brain by upregulating hepcidin, a key regulator of iron homeostasis, triggering ferroptosis. Since hepatocytes are the primary cells that produce hepcidin and control systemic iron levels, we investigated whether cerebral ischemia induces hepcidin upregulation in hepatocytes. Following middle cerebral artery occlusion (MCAO) in a rodent model, significant liver injury was observed. This injury was evidenced by significantly elevated Eckhoff’s scores and increased serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Additionally, total iron levels were significantly elevated in the liver, with intracellular iron accumulation detected in hepatocytes. Hepcidin expression in the liver, which is primarily localized in hepatocytes, increased significantly starting at 3 h after MCAO and continued to increase rapidly, reaching a peak at 24 h. Interestingly, HMGB1 levels in the liver were also significantly elevated after MCAO, with the disulfide form of HMGB1 being the major subtype. In vitro experiments using AML12 hepatocytes showed that recombinant disulfide HMGB1 significantly upregulated hepcidin expression in a Toll-like receptor 4 (TLR4)- and RAGE-dependent manner. Furthermore, treatment with a ROS scavenger and a peptide HMGB1 antagonist revealed that both ROS generation and HMGB1 induction contributed to hepatocyte activation and liver damage following MCAO–reperfusion. In conclusion, this study revealed that cerebral ischemia triggers hepatocyte activation and liver injury. HMGB1 potently induces hepcidin not only in the brain but also in the liver, thereby influencing systemic iron homeostasis following ischemic stroke.
Abstract
We previously reported that high mobility group box 1 (HMGB1), a danger-associated molecular pattern (DAMP), increases intracellular iron levels in the postischemic brain by upregulating hepcidin, a key regulator of iron homeostasis, triggering ferroptosis. Since hepatocytes are the primary cells that produce hepcidin and control systemic iron levels, we investigated whether cerebral ischemia induces hepcidin upregulation in hepatocytes. Following middle cerebral artery occlusion (MCAO) in a rodent model, significant liver injury was observed. This injury was evidenced by significantly elevated Eckhoff’s scores and increased serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Additionally, total iron levels were significantly elevated in the liver, with intracellular iron accumulation detected in hepatocytes. Hepcidin expression in the liver, which is primarily localized in hepatocytes, increased significantly starting at 3 h after MCAO and continued to increase rapidly, reaching a peak at 24 h. Interestingly, HMGB1 levels in the liver were also significantly elevated after MCAO, with the disulfide form of HMGB1 being the major subtype. In vitro experiments using AML12 hepatocytes showed that recombinant disulfide HMGB1 significantly upregulated hepcidin expression in a Toll-like receptor 4 (TLR4)- and RAGE-dependent manner. Furthermore, treatment with a ROS scavenger and a peptide HMGB1 antagonist revealed that both ROS generation and HMGB1 induction contributed to hepatocyte activation and liver damage following MCAO–reperfusion. In conclusion, this study revealed that cerebral ischemia triggers hepatocyte activation and liver injury. HMGB1 potently induces hepcidin not only in the brain but also in the liver, thereby influencing systemic iron homeostasis following ischemic stroke.
참고문헌 (53)
- Boelart, J, "Inorganic biochemistry of iron metabolism: from molecular mechan isms to clinical consequences" (2001), Wiley
- Singh, N, "Brain iron homeostasis : from molecular mechanisms to clinical sig nificance and therapeutic opportunities", Antioxid Redox Signal, 20, pp.1324~1363 (2014)
- Ganz, T, "Iron homeostasis in host defence and inflammation", Nat Rev Immunol, 15, pp.500~510 (2015)
- Urrutia, PJ, "Inflaming the Brain with Iron", Antioxidants, 10, pp.61~ (2021)
- Greenough, MA, "Metal dyshomeostasis and oxidative stress in Alzheimer’s disease", Neurochem Int, 62, pp.540~555 (2013)
- Raven, EP, "Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer’s disease detected in vivo with magnetic resonance imaging", J Alzheimers Dis, 37, pp.127~136 (2013)
- Dietrich, RB, "Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children", Radiology, 168, pp.203~206 (1988)
- Hare, DJ, "An iron-dopamine index predicts risk of Parkinsonian neurode generation in the substantia nigra pars compacta", Chem Sci, 5, pp.2160~2169 (2014)
- Skouta, R, "Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models", J Am Chem Soc, 136, pp.4551~4556 (2014)
- Millerot-Serrurot, E, "Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke", Neurochem Int, 52, pp.1442~1448 (2008)
- Garcia-Yebenes, I, "Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion", Neurochem Int, 61, pp.1364~1369 (2012)
- Tuo, QZ, "Tau-mediated iron export prevents ferroptotic damage after ischemic stroke", Mol Psychiatry, 22, pp.1520~1530 (2017)
- Slomka, A, "Hepcidin levels are increased in patients with acute ischemic stroke: preliminary report", J Stroke Cerebrovasc Dis, 24, pp.1570~1576 (2015)
- Petrova, J, "Ischemic stroke, inflam mation, iron overload- Connection to a hepcidin", Int J Stroke, 11, pp.NP16~NP17 (2016)
- Nemeth, E, "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization", Science, 306, pp.2090~2093 (2004)
- Nemeth, E, "The role of hepcidin in iron metabolism", Acta Haematol, 122, pp.78~86 (2009)
- Urrutia, P, "Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells", J Neurochem, 126, pp.541~549 (2013)
- Meynard, D, "The liver: conductor of systemic iron balance", Blood, 123, pp.168~176 (2014)
- Canali, S, "Activin B induces noncanonical SMAD1", 5, Endocrinology, pp.2016, 157[DOI]
- Davaanyam, D, "HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain", Exp Mol Med, 55, pp.2402~2416 (2023)
- Kim, JB, "HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain", J Neurosci, 26, pp.6413~6421 (2006)
- Kim, SW, "Glycyrrhizic acid affords robust neuroprotection in the post ischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion", Neurobiol Dis, 46, pp.147~156 (2012)
- Shin, JH, "Ethyl pyruvate inhibits HMGB1 phos phorylation and secretion in activated microglia and in the postischemic brain", Neurosci Lett, 558, pp.159~163 (2014)
- Petrova, JJ, "Is there a link between changes in levels of Hepcidin and stroke?", Clin Lab, 61, pp.1935~1939 (2015)
- Azab, SF, "Serum Hepcidin levels in childhood-onset ischemic stroke : a case control study", Medicine, 95, pp.e2921~ (2016)
- Xiong, XY, "Serum hepcidin concentrations correlate with serum iron level and outcome in patients with intracerebral hemorrhage", Neurol Sci, 36, pp.1843~1849 (2015)
- Lee, YS, "Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression", Exp Mol Med, 49, pp.e408~ (2017)
- Ma, SB, "Peripheral to central: Organ interactions in stroke pathophysiology", Exp Neurol, 272, pp.41~49 (2015)
- Tan, C, "Responses of immune organs after cerebral ischemic stroke", J Nippon Med Sch, 88, pp.228~237 (2021)
- Wang, J, "Peripheral organ injury after stroke", Front Immunol, 13, pp.901209~ (2022)
- Castillo, J, "Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke", Stroke, 27, pp.1060~1065 (1996)
- Campos, F, "High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke", J Cereb Blood Flow Metab, 31, pp.1387~1393 (2011)
- Muscari, A, "Changes of liver enzymes and bilirubin during ischemic stroke : mechanisms and possible significance", BMC Neurol, 14, pp.122~ (2014)
- Chan, PH, "Reactive oxygen radicals in signaling and damage in the ischemic brain", J Cereb Blood Flow Metab, 21, pp.2~14 (2001)
- Chen, H, "Oxidative stress in ischemic brain damage : mechanisms of cell ceth and potential molecular targets for neuroprotection", Antioxid Redox Signal, 14, pp.1505~1517 (2011)
- Goessling, W, "Aminotransferase levels and 20-year risk of metabolic syn drome, diabetes, and cardiovascular disease", Gastroenterology, 135, pp.1935~1944 (2008)
- Kunutsor, SK, "Liver enzymes and risk of cardiovascular disease in the general population: A meta-analysis of prospective cohort studies", Atherosclerosis, 236, pp.7~17 (2014)
- Higashitani, M, "Low Aspartate Aminotransferase(AST)", Alanine Aminotransferase(ALT)ratio associated with increased cardiovascular disease and its risk factors in healthy Japanese population, 2022, pp.31, 429~436
- Zhang, XT, "Ischemic stroke in liver cirrhosis : epidemiology, risk factors, and in-hospital outcomes", Eur J Gastroenterol Hepat, 30, pp.233~240 (2018)
- Parikh, NS, "Liver fibrosis is associated with ischemic stroke risk in womenbut not men : the REGARDS study", J Stroke Cerebrovasc Dis, 30, pp.105788~ (2021)
- Wu, M, "Non-alcoholic fatty liver disease and stroke : A Mendelian randomi zation study", Eur J Neurol, 29, pp.1534~1537 (2022)
- Sosa, RA, "Disulfide high-mobility Group Box 1 drives ischemia-reperfusion injury in human liver transplantation", Hepatology, 73, pp.1158~1175 (2021)
- Liu, Y, "Neutrophil extracellular traps regulate HMGB1 translocation and Kupffer cell M1 polarization during acute liver transplantation rejection", Front Immunol, 13, pp.823511~ (2022)
- Wen, J, "Paeoniflorin protects against intestinal ischemia", reperfusion by activating LKB1, Pharm Res, pp.2019, 146[DOI]
- Chen, L, "miR-103a-3p could attenuate sepsis-induced liver injury by tar geting HMGB1", Inflammation, 43, pp.2075~2086 (2020)
- Nakano, T, "Role of antinuclear antibodies in experimental and clinical liver transplantation", Transpl Proc, 38, pp.3605~3606 (2006)
- Faria, LC, "Circulating levels of High-mobility group box 1 protein and nucleosomes are associated with outcomes after liver transplant", Clin Transpl, 34, pp.e13869~ (2020)
- Ge, X, "High Mobility Group Box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice", Hepatology, 68, pp.2380~2404 (2018)
- Ni, YA, "HMGB1: An overview of its roles in the pathogenesis of liver disease", J Leukoc Biol, 110, pp.987~998 (2021)
- Kim, ID, "Alarmin HMGB1 induces systemic and brain inflammatory exacer bation in post-stroke infection rat model", Cell Death Dis, 9, pp.426~ (2018)
- Gnana-Prakasam, JP, "Hepcidin expression in mouse retina and its regulation via lipopolysaccharide", Toll-like receptor-4 pathway independent of Hfe, 2008, pp.411, 79~88
- Xiong, XY, "Toll-like receptor 4", MyD88-mediated signaling of hepcidin expression causing brain iron accumulation, oxidative injury, and cognitive impairment after intracerebral hemorrhage, 2016, pp.134, 1025~1038
- Ferrara, M, "Oxidation of HMGB1 Is a dynamically regulated process in physiological and pathological conditions", Front Immunol, 11, pp.1122~ (2020)